A citation-based method for searching scientific literature

F Riese, S Guloksuz, C Roventa, J D Fair, H Haravuori, T Rolko, D Flynn, D Giacco, V Banjac, N Jovanovic, N Bayat, C Palumbo, M Rusaka, O Kilic, J Augėnaitė, A Nawka, M Zenger, I Kekin, P Wuyts, E Barrett, N Bausch-Becker, J Mikaliūnas, E Del Valle, K Feffer, G A Lomax, J G Marques, S Jauhar. Eur Psychiatry 2015
Times Cited: 9







List of co-cited articles
16 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Choice of antipsychotic treatment by European psychiatry trainees: are decisions based on evidence?
Sameer Jauhar, Sinan Guloksuz, Olivier Andlauer, Greg Lydall, João Gama Marques, Luis Mendonca, Iolanda Dumitrescu, Costin Roventa, Nele De Vriendt, Jeroen Van Zanten,[...]. BMC Psychiatry 2012
22
33

Changing interactions between physician trainees and the pharmaceutical industry: a national survey.
Kirsten E Austad, Jerry Avorn, Jessica M Franklin, Mary K Kowal, Eric G Campbell, Aaron S Kesselheim. J Gen Intern Med 2013
50
22



Psychopharmacology curriculum field test.
Sidney Zisook, Richard Balon, Sheldon Benjamin, Eugene Beresin, David A Goldberg, Michael D Jibson, Grace Thrall. Acad Psychiatry 2009
8
25

Interactions of doctors with the pharmaceutical industry.
M A Morgan, J Dana, G Loewenstein, S Zinberg, J Schulkin. J Med Ethics 2006
59
22

Information from pharmaceutical companies and the quality, quantity, and cost of physicians' prescribing: a systematic review.
Geoffrey K Spurling, Peter R Mansfield, Brett D Montgomery, Joel Lexchin, Jenny Doust, Noordin Othman, Agnes I Vitry. PLoS Med 2010
255
22


Attitudes and relationship between physicians and the pharmaceutical industry in a public general hospital in Lima, Peru.
Aldo De Ferrari, Cesar Gentille, Long Davalos, Leandro Huayanay, German Malaga. PLoS One 2014
15
22

Pharmaceutical Industry-Sponsored Meals and Physician Prescribing Patterns for Medicare Beneficiaries.
Colette DeJong, Thomas Aguilar, Chien-Wen Tseng, Grace A Lin, W John Boscardin, R Adams Dudley. JAMA Intern Med 2016
234
22


Interactions between medical residents and drug companies: a national survey after the Mediator® affair.
François Montastruc, Guillaume Moulis, Aurore Palmaro, Virginie Gardette, Geneviève Durrieu, Jean-Louis Montastruc. PLoS One 2014
4
50

Physician report of industry gifts and quality of care.
Doohee Lee, Charles E Begley. Health Care Manage Rev 2016
3
66

Restrictions on pharmaceutical detailing reduced off-label prescribing of antidepressants and antipsychotics in children.
Ian Larkin, Desmond Ang, Jerry Avorn, Aaron S Kesselheim. Health Aff (Millwood) 2014
20
22

Health industry practices that create conflicts of interest: a policy proposal for academic medical centers.
Troyen A Brennan, David J Rothman, Linda Blank, David Blumenthal, Susan C Chimonas, Jordan J Cohen, Janlori Goldman, Jerome P Kassirer, Harry Kimball, James Naughton,[...]. JAMA 2006
460
22


Making sense of change: patients' views of diabetes and GP-led integrated diabetes care.
Letitia H Burridge, Michele M Foster, Maria Donald, Jianzhen Zhang, Anthony W Russell, Claire L Jackson. Health Expect 2016
21
11

Adult Patients' Perspectives on the Benefits and Harms of Overused Screening Tests: a Qualitative Study.
Anne Sutkowi-Hemstreet, Maihan Vu, Russell Harris, Noel T Brewer, Rowena J Dolor, Stacey L Sheridan. J Gen Intern Med 2015
32
11

Managing chronic orofacial pain: A qualitative study of patients', doctors', and dentists' experiences.
Sarah Peters, Joanna Goldthorpe, Cheryl McElroy, Elizabeth King, Hanieh Javidi, Martin Tickle, Vishal R Aggarwal. Br J Health Psychol 2015
25
11

Social influence: compliance and conformity.
Robert B Cialdini, Noah J Goldstein. Annu Rev Psychol 2004
694
11




Medical students' exposure to and attitudes about drug company interactions: a national survey.
Frederick S Sierles, Amy C Brodkey, Lynn M Cleary, Frederick A McCurdy, Matthew Mintz, Julia Frank, D Joanne Lynn, Jason Chao, Bruce Z Morgenstern, William Shore,[...]. JAMA 2005
123
11

Assessing the need for a multi-modal curriculum in psychopharmacology education.
Deepak Prabhakar, Richard Balon, Sidney Zisook. Acad Psychiatry 2012
2
50

Critical review of antipsychotic polypharmacy in the treatment of schizophrenia.
W Wolfgang Fleischhacker, Hiroyuki Uchida. Int J Neuropsychopharmacol 2014
107
11

Teaching psychopharmacology: two trainees' perspectives.
Anna M Georgiopoulos, Jeff C Huffman. Acad Psychiatry 2005
8
12

Old versus new medications: how much should be taught?
James W Jefferson. Acad Psychiatry 2005
14
11

World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia, part 2: update 2012 on the long-term treatment of schizophrenia and management of antipsychotic-induced side effects.
Alkomiet Hasan, Peter Falkai, Thomas Wobrock, Jeffrey Lieberman, Birte Glenthoj, Wagner F Gattaz, Florence Thibaut, Hans-Jürgen Möller. World J Biol Psychiatry 2013
240
11

Efficacy of antidepressants: a re-analysis and re-interpretation of the Kirsch data.
Konstantinos N Fountoulakis, Hans-Jürgen Möller. Int J Neuropsychopharmacol 2011
77
11

The medication process in a psychiatric hospital: are errors a potential threat to patient safety?
Ann Lykkegaard Soerensen, Marianne Lisby, Lars Peter Nielsen, Birgitte Klindt Poulsen, Jan Mainz. Risk Manag Healthc Policy 2013
17
11



Teaching psychopharmacology: introduction.
Richard Balon. Acad Psychiatry 2005
5
20

Specialist training in psychiatry in Europe--results of the UEMS-survey.
Winfried Lotz-Rambaldi, Ines Schäfer, Roelof ten Doesschate, Fritz Hohagen. Eur Psychiatry 2008
21
11


Teaching critical appraisal of articles on psychopharmacology.
Pavel Mohr, Cyril Höschl, Jan Volavka. Acad Psychiatry 2012
3
33

Initial severity and antidepressant benefits: a meta-analysis of data submitted to the Food and Drug Administration.
Irving Kirsch, Brett J Deacon, Tania B Huedo-Medina, Alan Scoboria, Thomas J Moore, Blair T Johnson. PLoS Med 2008
11

Polypharmacy with antidepressants in children and adolescents.
Covadonga M Díaz-Caneja, Ana Espliego, Mara Parellada, Celso Arango, Carmen Moreno. Int J Neuropsychopharmacol 2014
15
11

A proposal for an updated neuropsychopharmacological nomenclature.
Joseph Zohar, David J Nutt, David J Kupfer, Hans-Jurgen Moller, Shigeto Yamawaki, Michael Spedding, Stephen M Stahl. Eur Neuropsychopharmacol 2014
54
11

Training in psychiatry and psychotherapy in Germany.
D Naber, F Hohagen. Encephale 2008
5
20

World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, part 1: update 2012 on the acute treatment of schizophrenia and the management of treatment resistance.
Alkomiet Hasan, Peter Falkai, Thomas Wobrock, Jeffrey Lieberman, Birte Glenthoj, Wagner F Gattaz, Florence Thibaut, Hans-Jürgen Möller. World J Biol Psychiatry 2012
308
11

European Psychiatric Association (EPA) guidance on post-graduate psychiatric training in Europe.
S Mayer, R J van der Gaag, G Dom, D Wassermann, W Gaebel, P Falkai, C Schüle. Eur Psychiatry 2014
15
11

Psychiatry resident/fellow-initiated and -designed multi-modal psychopharmacology curriculum for major depression.
Kristina M Deligiannidis, Ragy R Girgis, Adam Lau, Richard Balon, Sidney Zisook. Acad Psychiatry 2012
5
20

A meta-synthesis of potentially inappropriate prescribing in older patients.
Shane Cullinan, Denis O'Mahony, Aoife Fleming, Stephen Byrne. Drugs Aging 2014
51
11

AGNP Consensus Guidelines for Therapeutic Drug Monitoring in Psychiatry: Update 2011.
C Hiemke, P Baumann, N Bergemann, A Conca, O Dietmaier, K Egberts, M Fric, M Gerlach, C Greiner, G Gründer,[...]. Pharmacopsychiatry 2011
511
11

World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of eating disorders.
Martin Aigner, Janet Treasure, Walter Kaye, Siegfried Kasper. World J Biol Psychiatry 2011
104
11


History, background, concepts and current use of comedication and polypharmacy in psychiatry.
H-J Möller, F Seemüller, R Schennach-Wolff, S Stübner, E Rüther, R Grohmann. Int J Neuropsychopharmacol 2014
25
11



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.